Free Trial

CannaPharmaRX Q2 2023 Earnings Report

CannaPharmaRX logo
$0.0048 +0.00 (+20.00%)
As of 04/1/2025 11:13 AM Eastern

CannaPharmaRX EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

CannaPharmaRX Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

CannaPharmaRX Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Remove Ads

CannaPharmaRX Earnings Headlines

PSIQ Profile Solutions, Inc.
Trump to unlock 15-figure fortune for America (May 3rd) ?
We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.
CannaPharmaRX, Inc. (CPMD)
CannaPharmaRx to Host Investor Conference Call
See More CannaPharmaRX Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CannaPharmaRX? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CannaPharmaRX and other key companies, straight to your email.

About CannaPharmaRX

CannaPharmaRX (OTCMKTS:CPMD) operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.

View CannaPharmaRX Profile

More Earnings Resources from MarketBeat